文献速递腹部CT

胰腺CT检查中减少对比剂用量与辐射剂量:时机特异性对比剂方案

Reduced Contrast Volume and Radiation Dose During Computed Tomography of the Pancreas: Timing-Specific Contrast Media Protocol.
PubMed 文献 · Acad Radiol · 2018-08-17

该研究在220例连续患者中比较两种胰腺CT方案:A方案为100mL对比剂经定时团注触发技术注射,B方案为在胃十二指肠动脉水平定时注射的患者特异性对比剂方案。结果显示B方案胰腺各段密度及部分动脉强化更高、对比剂用量和有效剂量更低,图像质量与病灶检出曲线下面积更高。

要点

  • B方案动脉期胰腺密度96.59 HU、静脉期91.28 HU,均高于A方案(77.86 HU、73.99 HU)。
  • B方案对比剂用量57.60±12.25 mL,低于A方案的100±1 mL;有效剂量2.75±0.63 mSv,低于A方案的4.015±0.89 mSv。
  • B方案胰腺病灶检出的ROC与VGC曲线下面积显著更高,读者间一致性由good提升至excellent。

核心结论

  • 时机特异性对比剂方案在降低对比剂用量和辐射剂量的同时提高了胰腺CT图像质量。

研究设计与样本

  • 混合前瞻性与回顾性研究,经机构审查委员会批准,连续纳入220例患者,比较A方案(100mL对比剂经定时团注触发技术注射)与B方案(患者特异性对比剂方案,于胃十二指肠动脉定时),两方案均采用4.5 mL/s对比剂和100mL生理盐水冲管。

关键影像表现/征象

  • 动脉期与静脉期胰腺各段平均密度在B方案均显著高于A方案(动脉期96.59 HU±27.37 vs 77.86 HU±21.14,静脉期91.28 HU±20.88 vs 73.99 HU±14.75,p<0.0001)。
  • 动脉期腹主动脉(p<0.007)、肠系膜上动脉(p<0.0002)、胃十二指肠动脉近段(p<0.014)及脾动脉(p<0.036)强化B方案显著高于A方案。
  • 静脉期下腔静脉、肠系膜上静脉、门静脉及脾静脉各段强化B方案显著低于A方案(p<0.001)。
  • ROC与VGC分析显示B方案曲线下面积分别显著更高(p<0.0001与p<0.034),胰腺病灶检出读者间一致性由good提升至excellent。

诊断标准与关键数值

  • B方案对比剂用量57.60±12.25 mL显著低于A方案100±1 mL(p<0.001)。
  • B方案有效剂量2.75±0.63 mSv显著低于A方案4.015±0.89 mSv(p<0.001)。
  • B方案胰腺病灶检出的ROC曲线下面积显著高于A方案(p<0.0001),VGC曲线下面积亦显著更高(p<0.034)。

临床应用与阅片要点

  • 作者结论认为时机特异性对比剂方案可在降低对比剂用量和辐射剂量的同时提高胰腺CT图像质量。
  • 原文未据此给出具体的临床推荐或阅片操作建议。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVE: To investigate the opacification of the pancreatic vasculature and parenchyma during computed tomography utilizing a patient-specific contrast formula.

MATERIALS AND METHODS: This hybrid prospective and retrospective study was approved by the institution review board. In 220 consecutive patients, pancreatic CT was performed with one of two protocols: protocol A, 100mL of contrast material injected via timed bolus triggering technique; or protocol B, employing a patient-specific contrast media protocol specifically timed at the gastroduodenal artery; both protocols employed 4.5 mL/s contrast media and 100mL saline chaser. Attenuation of pancreatic parenchymal, arterial, and venous vasculature supplying the pancreas was measured. Effective dose was calculated. Data were compared to the independent two-sample t test. Receiver operating characteristic, visual grading characteristic, and Cohens' kappa analyses were performed.

RESULTS: Mean pancreatic density measurements in each of the pancreatic segments during the arterial and venous phase were significantly higher in Protocol B (mean ± standard deviation, art: 96.59 HU ± 27.37; venous: 91.28 HU ± 20.88) compared to A (art: 77.86 HU ± 21.14; venous: 73.99 HU ± 14.75) (p < 0.0001). Mean arterial opacification was significantly higher in protocol B compared to A with the abdominal aorta (p < 0.007), superior mesenteric (p < 0.0002), gastroduodenal (proximal segment only p < 0.014), and splenic arteries (p < 0.036). In the venous circulation, the inferior vena cava, superior mesenteric, portal and splenic veins (all segments) demonstrated significant reduction in vascular opacification protocol B compared to A (p < 0.001). The contrast media volume in protocol B (57.60 ± 12.25 mL) was significantly lower than in protocol A (100 ± 1 mL) (p < 0.001). Effective dose was significantly reduced in protocol B (2.75 ± 0.63 mSv) compared to A (4.015 ± 0.89 mSv) (p < 0.001). Receiver operating characteristic and visual grading characteristic analysis demonstrated significantly higher area under the curve for protocol B (p < 0.0001) (p < 0.034) respectively, with inter-reader agreement increasing from good to excellent in pancreatic lesion detection.

CONCLUSION: Timing-specific contrast media protocol enhances image quality at reduced contrast volume and radiation dose during computed tomography of the pancreas.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Saade C, Chokr J, Naffaa L, et al. Reduced Contrast Volume and Radiation Dose During Computed Tomography of the Pancreas: Timing-Specific Contrast Media Protocol. Acad Radiol. 2018. PMID: 30122624. doi:10.1016/j.acra.2018.05.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。